BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 20188700)

  • 1. The role of anthrolysin O in gut epithelial barrier disruption during Bacillus anthracis infection.
    Bishop BL; Lodolce JP; Kolodziej LE; Boone DL; Tang WJ
    Biochem Biophys Res Commun; 2010 Apr; 394(2):254-9. PubMed ID: 20188700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular functions and X-ray structure of anthrolysin O, a cholesterol-dependent cytolysin secreted by Bacillus anthracis.
    Bourdeau RW; Malito E; Chenal A; Bishop BL; Musch MW; Villereal ML; Chang EB; Mosser EM; Rest RF; Tang WJ
    J Biol Chem; 2009 May; 284(21):14645-56. PubMed ID: 19307185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Bacillus anthracis cholesterol-dependent cytolysin, Anthrolysin O, kills human neutrophils, monocytes and macrophages.
    Mosser EM; Rest RF
    BMC Microbiol; 2006 Jun; 6():56. PubMed ID: 16790055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacillus anthracis anthrolysin O and three phospholipases C are functionally redundant in a murine model of inhalation anthrax.
    Heffernan BJ; Thomason B; Herring-Palmer A; Hanna P
    FEMS Microbiol Lett; 2007 Jun; 271(1):98-105. PubMed ID: 17419764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric pH and Toxin Factors Modulate Infectivity and Disease Progression After Gastrointestinal Exposure to Bacillus anthracis.
    Xie T; Rotstein D; Sun C; Fang H; Frucht DM
    J Infect Dis; 2017 Dec; 216(11):1471-1475. PubMed ID: 28968672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Passive administration of monoclonal antibodies to anthrolysin O prolong survival in mice lethally infected with Bacillus anthracis.
    Nakouzi A; Rivera J; Rest RF; Casadevall A
    BMC Microbiol; 2008 Sep; 8():159. PubMed ID: 18811967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of lethal toxin and edema toxin to the pathogenesis of anthrax meningitis.
    Ebrahimi CM; Sheen TR; Renken CW; Gottlieb RA; Doran KS
    Infect Immun; 2011 Jul; 79(7):2510-8. PubMed ID: 21518787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo murine and in vitro M-like cell models of gastrointestinal anthrax.
    Tonry JH; Popov SG; Narayanan A; Kashanchi F; Hakami RM; Carpenter C; Bailey C; Chung MC
    Microbes Infect; 2013 Jan; 15(1):37-44. PubMed ID: 23108317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galactosylation of the Secondary Cell Wall Polysaccharide of Bacillus anthracis and Its Contribution to Anthrax Pathogenesis.
    Chateau A; Lunderberg JM; Oh SY; Abshire T; Friedlander A; Quinn CP; Missiakas DM; Schneewind O
    J Bacteriol; 2018 Mar; 200(5):. PubMed ID: 29229702
    [No Abstract]   [Full Text] [Related]  

  • 10. plcR papR-independent expression of anthrolysin O by Bacillus anthracis.
    Ross CL; Koehler TM
    J Bacteriol; 2006 Nov; 188(22):7823-9. PubMed ID: 16980467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anthrolysin O and fermentation products mediate the toxicity of Bacillus anthracis to lung epithelial cells under microaerobic conditions.
    Popova TG; Millis B; Chung MC; Bailey C; Popov SG
    FEMS Immunol Med Microbiol; 2011 Feb; 61(1):15-27. PubMed ID: 20946354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacillus anthracis lethal toxin reduces human alveolar epithelial barrier function.
    Langer M; Duggan ES; Booth JL; Patel VI; Zander RA; Silasi-Mansat R; Ramani V; Veres TZ; Prenzler F; Sewald K; Williams DM; Coggeshall KM; Awasthi S; Lupu F; Burian D; Ballard JD; Braun A; Metcalf JP
    Infect Immun; 2012 Dec; 80(12):4374-87. PubMed ID: 23027535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Passive Immunotherapy Protects against Enteric Invasion and Lethal Sepsis in a Murine Model of Gastrointestinal Anthrax.
    Huang B; Xie T; Rotstein D; Fang H; Frucht DM
    Toxins (Basel); 2015 Sep; 7(10):3960-76. PubMed ID: 26426050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MyD88-dependent signaling protects against anthrax lethal toxin-induced impairment of intestinal barrier function.
    Okugawa S; Moayeri M; Eckhaus MA; Crown D; Miller-Randolph S; Liu S; Akira S; Leppla SH
    Infect Immun; 2011 Jan; 79(1):118-24. PubMed ID: 20974827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunisation with anthrolysin O or a genetic toxoid protects against challenge with the toxin but not against Bacillus anthracis.
    Cowan GJ; Atkins HS; Johnson LK; Titball RW; Mitchell TJ
    Vaccine; 2007 Oct; 25(41):7197-205. PubMed ID: 17765365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anthrolysin O and other gram-positive cytolysins are toll-like receptor 4 agonists.
    Park JM; Ng VH; Maeda S; Rest RF; Karin M
    J Exp Med; 2004 Dec; 200(12):1647-55. PubMed ID: 15611291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacillus anthracis factors for phagosomal escape.
    Tonello F; Zornetta I
    Toxins (Basel); 2012 Jul; 4(7):536-53. PubMed ID: 22852067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of anthrax lethal toxin on host barrier function.
    Xie T; Auth RD; Frucht DM
    Toxins (Basel); 2011 Jun; 3(6):591-607. PubMed ID: 22069727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anthrax lethal toxin disrupts intestinal barrier function and causes systemic infections with enteric bacteria.
    Sun C; Fang H; Xie T; Auth RD; Patel N; Murray PR; Snoy PJ; Frucht DM
    PLoS One; 2012; 7(3):e33583. PubMed ID: 22438953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-time monitoring of the membrane-binding and insertion properties of the cholesterol-dependent cytolysin anthrolysin O from Bacillus anthracis.
    Cocklin S; Jost M; Robertson NM; Weeks SD; Weber HW; Young E; Seal S; Zhang C; Mosser E; Loll PJ; Saunders AJ; Rest RF; Chaiken IM
    J Mol Recognit; 2006; 19(4):354-62. PubMed ID: 16775845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.